Table 1 Baseline patient demographics (n = 36)
Characteristics | Vaginal cancer (n = 16) | Vulvar cancer (n = 20) |
|---|---|---|
Median age, years (range) | 60 (30 to 85) | 55 (33 to 78) |
Race, n (%) | ||
White | 13 (81 %) | 19 (95 %) |
Black | 1 (6 %) | 0 |
Hispanic | 2 (13 %) | 0 |
Asian | 0 | 1 (5 %) |
Body Mass Index, n (%) | ||
Underweight (<18.5) | 0 | 1 (5 %) |
Normal Weight (18.5 to 25) | 10 (62 %) | 13 (65 %) |
Overweight (>25) | 6 (38 %) | 6 (30 %) |
The Eastern Cooperative Oncology Group Performance Status, n (%) | ||
0 | 4 (25 %) | 0 |
1 | 9 (56 %) | 18 (90 %) |
2 | 3 (19 %) | 2 (10 %) |
Prior Chemotherapy | ||
Yes, n (%) | 14 (88 %) | 16 (80 %) |
Median number (range) | 2 (0 to 4) | 1 (0 to 6) |
Prior Radiation Therapy | ||
Yes, n (%) | 15 (94 %) | 17 (85 %) |
Pathological Diagnosis, n (%) | ||
Squamous Cell Carcinoma | 7 (44 %) | 17 (85 %) |
Adenocarcinoma | 4 (25 %) | 0 |
Melanoma | 3 (19 %) | 3 (15 %) |
Carcinosarcoma | 1 (6 %) | 0 |
High-grade neuroendocrine carcinoma | 1 (6 %) | 0 |
Phase I Trial Enrollment, n (%) | 11 (69 %) | 16 (80 %) |